Similar results were seen in breast cancer cell lines, as stable overexpression of SOX2 in MCF-7 cells promoted resistance to tamoxifen, while stable downregulation of SOX2 using shRNAs enhanced the sensitivity of MCF-7 cells to tamoxifen [38]. Here, SOX2 is linked to breast carcinoma.